Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
XMD 8-92, is a BMK1 inhibitor and a highly selective inhibitor of ERK5 activity. XMD8-92 blocks cellular BMK1 activation and significantly suppresses tumor growth in lung and cervical tumor models and is well tolerated in animals.
?您的位置：
